Soligenix Q4 EPS $(0.29) Beats $(0.56) Estimate

4/1/2026
Impact: 70
Healthcare

Soligenix (NASDAQ: SNGX) reported a Q4 loss of $(0.29) per share, surpassing the analyst consensus estimate of $(0.56) by 48.75%. This represents a significant improvement, with losses decreasing by 74.82% compared to $(1.14) per share in the same quarter last year.

AI summary, not financial advice

Share: